PolyPid Ltd. is a pharmaceutical company focused on the development and commercialization of novel drug delivery solutions. Utilizing its proprietary PLEX technology, the company aims to improve therapeutic outcomes by providing sustained drug release at the site of treatment. With an impressive pipeline of products targeting various indications, PolyPid is poised to make a significant impact in the field of drug delivery.
